Home > Riviste > Italian Journal of Vascular and Endovascular Surgery > Fascicoli precedenti > Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4) > Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4):183-9

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Rivista di Chirurgia Vascolare ed Endovascolare


Official Journal of the Italian Society of Vascular and Endovascular Surgery
Indexed/Abstracted in: EMBASE, Emerging Sources Citation Index, Scopus


eTOC

 

  PERIPHERAL ARTERIAL DISEASES


Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4):183-9

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of drug-eluting balloons for the in-stent restenosis in femoro-popliteal interventions

Cannavale A., Krokidis M.

Department of Radiology, Cambridge University Hospitals NHS Trust, Cambridge, UK


PDF  


In-stent restenosis (ISR) remains one of the main drawbacks of stenting the femoropopliteal segment, and leads to stent dysfunction and repeated interventions. A variety of endovascular techniques have been investigated so far to reduce this phenomenon, including plain angioplasty, atherectomy, new stent deployment, cutting balloons and cryoplasty but without satisfactory mid- and long-term results.
Drug eluting balloons (DEBs) are recently developed and have shown promising results in the treatment of native femoropopliteal disease; the use of these novel devices has extended in the treatment of ISR. The main advantage of DEBs in the treatment of ISR is the reduction of the chronic inflammatory factors. Purpose of this review is to delineate the role of DEBs in the treatment of ISR of the femoropopliteal arteries.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail